69
Growth Score
pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1278920
NeoNeuro applies aptamer technology to enhance Alzheimer's disease diagnosis and treatment.
- Gregory Penner: Founder & President
About the Company
NeoNeuro focuses on the application of aptamer technology to improve the treatment and diagnosis of Alzheimer's disease. The company leverages enriched aptamer libraries to develop biomarkers for neurological disorders. NeoNeuro's platform aims to enable personalized medicine by providing deep biomarker fingerprinting for blood diagnostic
tests. The company collaborates with various organizations and has received investment from the Alzheimer's Drug Discovery Foundation (ADDF).
